Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ), 'continue to see JNJ as one of our Top Picks'
Tweet Send to a Friend
Guggenheim analyst Vamil Divan reiterated a Buy rating and $244.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
